EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

Endothelin-1 impairs skeletal muscle myogenesis and development via ETB receptors and p38 MAPK signaling pathway

Shui-Yu Liu, Luei-Kui Chen, Yi-Ting Jhong, Chien-Wei Chen, Li-En Hsiao, Huei-Chi Ku, Pin-Hsuan Lee, Guey-Shyang Hwang, Chi-Chang Juan iD

Clinical Science · 19.06.2024 · 138 (12) · 711-723

DOI: 10.1042/cs20240341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, online erschienen am 11.06.2024. Verfasst von Shui-Yu Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institutes of Physiology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, 112304, Taiwan. Hauptthemen laut MEDLINE: Cell Differentiation, Cell Proliferation, Endothelin-1, Muscle Development. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: National Science and Technology Council (NSTC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myopenia is a condition marked by progressive decline of muscle mass and strength and is associated with aging or obesity. It poses the risk of falling, with potential bone fractures, thereby also increasing the burden on family and society. Skeletal muscle wasting is characterized by a reduced number of myoblasts, impaired muscle regeneration and increased muscle atrophy markers (Atrogin-1, MuRF-1). Endothelin-1 (ET-1) is a potent vasoconstrictor peptide. Increased circulating levels of ET-1 is noted with aging and is associated with muscular fibrosis and decline of strength. However, the regulatory mechanism controlling its effect on myogenesis and atrophy remains unknown. In the present study, the effects of ET-1 on myoblast proliferation, differentiation and development were investigated in C2C12 cells and in ET-1-infused mice. The results show that ET-1, acting via ETB receptors, reduced insulin-stimulated cell proliferation, and also reduced MyoD, MyoG and MyHC expression in the differentiation processes of C2C12 myoblasts. ET-1 inhibited myoblast differentiation through ETB receptors and the p38 mitogen-activated protein kinase (MAPK)-dependent pathway. Additionally, ET-1 decreased MyHC expression in differentiated myotubes. Inhibition of proteasome activity by MG132 ameliorated the ET-1-stimulated protein degradation in differentiated C2C12 myotubes. Furthermore, chronic ET-1 infusion caused skeletal muscle atrophy and impaired exercise performance in mice. In conclusion, ET-1 inhibits insulin-induced cell proliferation, impairs myogenesis and induces muscle atrophy via ETB receptors and the p38 MAPK-dependent pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell DifferentiationCell ProliferationEndothelin-1Muscle DevelopmentMuscle, Skeletalp38 Mitogen-Activated Protein KinasesAnimalsMiceCell LineMAP Kinase Signaling SystemMice, Inbred C57BLMuscular AtrophyMyoblastsSignal Transduction

Stichwörter der Autor:innen

atrophyendothelinmyogenesisp38 MAPKproliferation

Substanzen

Endothelin-1p38 Mitogen-Activated Protein Kinases

Autor:innen und Institutionen

  • Institutes of Physiology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, 112304, Taiwan.
  • Department of Physical Education, Health, and Recreation, Teachers College, National Chiayi University, Chiayi, 621302, Taiwan.
  • Department of Nursing, Chang Gung University of Science and Technology, Taoyuan, 33303, Taiwan.
  • Department of Medical Research, Taipei Veterans General Hospital, Taipei 112201, Taiwan.

ORCID-Profile: Chi-Chang Juan

Förderung

  • National Science and Technology Council (NSTC)

Zitieren

APA

Liu, S. Y., Chen, L. K., Jhong, Y. T., Chen, C. W., Hsiao, L. E., Ku, H. C., Lee, P. H., Hwang, G. S., & Juan, C. C. (2024). Endothelin-1 impairs skeletal muscle myogenesis and development via ETB receptors and p38 MAPK signaling pathway. Clinical Science, 138(12), 711-723. https://doi.org/10.1042/cs20240341

Vancouver

Liu SY, Chen LK, Jhong YT, Chen CW, Hsiao LE, Ku HC, et al. Endothelin-1 impairs skeletal muscle myogenesis and development via ETB receptors and p38 MAPK signaling pathway. Clinical Science. 2024;138(12):711-723. doi:10.1042/cs20240341

BibTeX
@article{Liu2024,
  author = {Liu, Shui-Yu and Chen, Luei-Kui and Jhong, Yi-Ting and Chen, Chien-Wei and Hsiao, Li-En and Ku, Huei-Chi and Lee, Pin-Hsuan and Hwang, Guey-Shyang and Juan, Chi-Chang},
  title = {Endothelin-1 impairs skeletal muscle myogenesis and development via ETB receptors and p38 MAPK signaling pathway},
  journal = {Clinical Science},
  year = {2024},
  volume = {138},
  number = {12},
  pages = {711--723},
  doi = {10.1042/cs20240341}
}
Kostenlos starten →